Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Gliatech prepares H3 agonists

Feb. 19, 1997

Antidepressant with minimal impact on sexual function introduced

Feb. 18, 1997

TCR peptides for MS reported by Connective Therapeutics

Feb. 18, 1997

Yeda discloses peptides for myasthenia gravis

Feb. 18, 1997

Abbott discloses nicotinic cholinergic channel modulators

Feb. 18, 1997

Adenosine kinase inhibitors prepared by Gensia

Feb. 18, 1997

Ampalex trial in AD begins

Feb. 17, 1997

GDNF gene therapy for Parkinson's disease

Feb. 17, 1997

Third launch for Zyprexa

Feb. 17, 1997

Nymox drug candidate for AD to enter phase I

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...